ArticleMolecular & cellular proteomics : MCP2018

Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Marie Duhamel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.